Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
115 participants
OBSERVATIONAL
2016-01-01
2017-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Role of Vaspin in Pathophysiology of Pre-eclampsia
NCT06437535
The Expression of Aquaporin 3, 8 and 9 in Placenta in Normal and Preeclamptic Pregnancies: Perinatal and Neonatal Outcomes.
NCT02045316
Maternal and Neonatal Outcome in Severe Preeclampsia
NCT04126122
Ambulatory Blood Pressure Monitoring in Post-Partum Pre-Eclamptic Patients
NCT02943122
Restrictive Fluid Therapy in Severe Preeclampsia
NCT02214186
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Methods: This retrospective cohort designed study was conducted on 115 pregnant women with placental abruption. The main parameters scanned and recorded from the hospital database and patient medical files. Two groups were classified regarding of presence or absence of hypertension (53 hypertensive, 62 normotensive). Maternal demographical and clinical characteristics (abdominal pain, vaginal bleeding) were recorded. APGAR scores below 5 at 1 and 5 min., fetal or neonatal death, admission and length of stay in Neonatal Intensive Care Unit(NICU) were also investigated and compared between the groups.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1 (with hypertension )
Two groups were classified regarding of presence or absence of hypertension (53 hypertensive, 62 normotensive).
clinical assesment
Comparison of Hypertensive group and normotensive group
Group 2( without hypertension)
Two groups were classified regarding of presence or absence of hypertension (53 hypertensive, 62 normotensive).
clinical assesment
Comparison of Hypertensive group and normotensive group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
clinical assesment
Comparison of Hypertensive group and normotensive group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* singleton pregnancies
* above 25 weeks of gestations with positive fetal cardiac activity
Exclusion Criteria
* presence of fetal or maternal infection,
* chronic inflammatory diseases or connective tissue disorders
* history of myocardial infarction,
* thrombosis
* history of steroid drug usage.
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hatice Akkaya
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hatice Akkaya
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hatice Akkaya, Ass Prof
Role: PRINCIPAL_INVESTIGATOR
Kayseri Education and Research Hospital
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E52332816/49
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.